Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting the activation of Factor XIII

Methods of inhibiting the activation of Factor XIII

US Patent 5620688 · Granted Apr 15, 1997

Estimated economic value: $55,847,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury2022
Serpinf2-binding molecules and method of use thereof2022
Prophylaxis of thrombosis2021
Specific plasmin inactivation by anticatalytic antibody2021
Tissue plasminogen activator antibodies and methods of use2020
Tissue plasminogen activator antibodies and methods of use2018
Method of increasing plasmin activity through antiplasmin conversion2017
Method of increasing plasmin activity through antiplasmin conversion2015
Baboon TAFI polypeptides2007
Nucleic acid molecules and polypeptides encoding baboon TAFI2006
Platelet activation protein2004
Antibodies that bind to &agr;2-antiplasmin crosslinked to fibrin which do not in2003